Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENSIFENTRINE vs ENZALUTAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENSIFENTRINE vs ENZALUTAMIDE: Safety Overview

Metric ENSIFENTRINE ENZALUTAMIDE
Total FAERS Reports 410 49,270
Deaths Reported 2 9,676
Death Rate 0.5% 19.6%
Hospitalizations 77 9,282
Average Patient Age 71.7 yrs 76.0 yrs
% Female Patients 51.6% 0.6%
FDA Approval Date Jun 26, 2024 Apr 22, 2022
Manufacturer Verona Pharma, Inc. Astellas Pharma US, Inc.
Route RESPIRATORY (INHALATION) ORAL
Marketing Status Prescription Prescription